Literature DB >> 8391930

Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin.

M L Nonet1, K Grundahl, B J Meyer, J B Rand.   

Abstract

Synaptotagmin is an abundant synaptic vesicle-associated protein proposed to be involved in calcium-mediated neurotransmitter release. Our molecular and genetic results demonstrate that, although synaptotagmin is required for the proper function of the presynaptic nerve terminal in C. elegans, some neurotransmitter release persists in synaptogamin mutants. In C. elegans neurons, synaptotagmin is localized to regions known to be rich in synapses and appears to be associated with synaptic vesicles. Mutants defective in the synaptotagmin gene, called snt-1, exhibit severe behavioral abnormalities that are characteristic of deficiencies in synaptic function, including severe locomotion, feeding, and defecation defects. The mutants are defective in exocytosis, since they accumulate acetylcholine, and are resistant to cholinesterase inhibitors, but they nevertheless remain sensitive to cholinergic receptor agonists. In spite of these exocytic defects, snt-1 mutants are capable of coordinated motor movements, indicating that the mutants do not have a complete block of neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391930     DOI: 10.1016/0092-8674(93)90357-v

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  186 in total

1.  Neurosecretory control of aging in Caenorhabditis elegans.

Authors:  M Ailion; T Inoue; C I Weaver; R W Holdcraft; J H Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Deficits in memory and motor performance in synaptotagmin IV mutant mice.

Authors:  G D Ferguson; S G Anagnostaras; A J Silva; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  Protein-protein interactions and protein modules in the control of neurotransmitter release.

Authors:  F Benfenati; F Onofri; S Giovedí
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

4.  A post-docking role for active zone protein Rim.

Authors:  S P Koushika; J E Richmond; G Hadwiger; R M Weimer; E M Jorgensen; M L Nonet
Journal:  Nat Neurosci       Date:  2001-10       Impact factor: 24.884

5.  Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits.

Authors:  J T Fleming; M D Squire; T M Barnes; C Tornoe; K Matsuda; J Ahnn; A Fire; J E Sulston; E A Barnard; D B Sattelle; J A Lewis
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

6.  The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretion.

Authors:  M Pilon; X R Peng; A M Spence; R H Plasterk; H M Dosch
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

7.  Expression of multiple UNC-13 proteins in the Caenorhabditis elegans nervous system.

Authors:  R E Kohn; J S Duerr; J R McManus; A Duke; T L Rakow; H Maruyama; G Moulder; I N Maruyama; R J Barstead; J B Rand
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

8.  PKN-1, a homologue of mammalian PKN, is involved in the regulation of muscle contraction and force transmission in C. elegans.

Authors:  Hiroshi Qadota; Takayuki Miyauchi; John F Nahabedian; Jeffrey N Stirman; Hang Lu; Mutsuki Amano; Guy M Benian; Kozo Kaibuchi
Journal:  J Mol Biol       Date:  2011-01-26       Impact factor: 5.469

9.  Solution single-vesicle assay reveals PIP2-mediated sequential actions of synaptotagmin-1 on SNAREs.

Authors:  Jae-Yeol Kim; Bong-Kyu Choi; Mal-Gi Choi; Sun-Ae Kim; Ying Lai; Yeon-Kyun Shin; Nam Ki Lee
Journal:  EMBO J       Date:  2012-03-09       Impact factor: 11.598

10.  Latrophilin is required for toxicity of black widow spider venom in Caenorhabditis elegans.

Authors:  Christopher J Mee; Simon R Tomlinson; Pavel V Perestenko; David De Pomerai; Ian R Duce; Peter N R Usherwood; David R Bell
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.